-transparent.png){kind=logo}
Measles-mumps-rubella vaccine (MMR) is recommended for human immunodeficiency virus-infected (HIV+) adults. Data concerning MMR vaccination of HIV+ patients are limited to children. We evaluated 39 HIV+ (97% with > 200 CD4+ lymphocytes) and 17 non-HIV+ control adults receiving measles-rubella vaccine (MR). Clinical adverse events did not differ between groups. Prevaccination, three HIV+ and two control vaccinees were measles seronegative; no HIV+ and one control vaccinee seroconverted. No initially measles-seropositive vaccinee had a significant antibody elevation. Four HIV+ and three control vaccinees were rubella seronegative prevaccination; three HIV+ and two control vaccinees seroconverted. Among those initially rubella seropositive, two HIV+ and one control vaccinee had significant antibody elevations. There were no significant percentage CD4+ or CD8+ lymphocyte changes between groups. Three HIV+ vaccinees were p24 antigen positive pre- and postvaccination. Although MR vaccination appears safe in HIV+ adults, questions remain about the response of measles and rubella antibody-negative HIV+ adults and those with < 200 CD4+ lymphocytes.
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
July 2022,
AIDS (London, England),
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
October 1992,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
March 1992,
The Journal of infectious diseases,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
September 2015,
AIDS patient care and STDs,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
April 2016,
BMC infectious diseases,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
November 1991,
The Journal of infectious diseases,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
April 2011,
Vaccine,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
May 2023,
Vacunas,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
March 2005,
Kidney international,
M A Sprauer, and
L E Markowitz, and
J K Nicholson, and
R C Holman, and
A Deforest, and
L G Dales, and
N K Khoury
May 1989,
JAMA,
